CriticalConditionally essential amino acid, precursor of catecholamines and thyroid hormones×Antidepressant, irreversible non-selective monoamine oxidase inhibitor (MAO-A and MAO-B)
Updated · Methodology
Mechanism
L-tyrosine is an amino acid from which the body makes dopamine, noradrenaline and adrenaline. Phenelzine is a potent monoamine oxidase (MAO) inhibitor (phenelzine label, US Food and Drug Administration, FDA, Description), and MAO inhibitors block the breakdown of serotonin and noradrenaline (FDA phenelzine label, Precautions). According to the phenelzine label, MAO inhibitors potentiate sympathomimetic substances and related compounds, L-tyrosine among them, and this may result in hypertensive crises (FDA phenelzine label, Contraindications).
Symptoms
The main risk of the combination is a hypertensive crisis (phenelzine label, US Food and Drug Administration, FDA, Contraindications). A hypertensive crisis with phenelzine presents with an occipital headache that may spread to the forehead, palpitations, neck stiffness or soreness, nausea, vomiting, sweating (sometimes with fever and sometimes with cold, clammy skin), dilated pupils and sensitivity to light. The heart rate may be fast or slow, sometimes with constricting chest pain. Intracranial bleeding has occurred with the rise in blood pressure, and some crises have been fatal (FDA phenelzine label, Warnings).
Management
The combination is contraindicated: the US phenelzine label lists L-tyrosine among the compounds related to sympathomimetics that patients treated with phenelzine should not take (phenelzine label, US Food and Drug Administration, FDA, Contraindications). Phenelzine is not authorised in Spain, and in the Spanish medicines register L-tyrosine appears only in multi-ingredient products, mostly solutions for intravenous nutrition (medicines register of the Spanish Agency of Medicines and Medical Devices, AEMPS). The severity rating therefore follows the phenelzine label. The label gives no separate interval for L-tyrosine after stopping phenelzine. Avoid the foods and over-the-counter medicines on the label's patient list during treatment and for two weeks after stopping (FDA phenelzine label, Warnings). With phenelzine, check blood pressure often and stop phenelzine at once if palpitations or frequent headaches appear (FDA phenelzine label, Warnings). In a hypertensive crisis, stop phenelzine and start lowering blood pressure immediately: the US phenelzine label recommends phentolamine (a reported dose of 5 mg intravenously), given slowly to avoid an excessive fall in blood pressure (FDA phenelzine label, Warnings). Manage fever during the crisis with external cooling (FDA phenelzine label, Warnings).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Nardil (phenelzine sulfate tablets, USP) – prescribing information (2025)– FDA label, Parke-Davis Div of Pfizer, DailyMed setid 513a41d0-37d4-4355-8a6d-a2c643bce6fa, version 11, 06/2025, INDICATIONS AND USAGE, CONTRAINDICATIONS, PRECAUTIONS: Drug Interactions